Caffeine restriction can improve, reduce severity of bed-wetting

Caffeine restriction can improve, reduce severity of bed-wetting

Caffeine restriction can help improve and reduce the severity of primary monosymptomatic nocturnal enuresis (PMNE), according to a study recently published in BMJ Paediatrics Open.

Sadra Rezakhaniha, from the Islamic Azad University Science and Research Branch Faculty of Basic Sciences in Tehran, Iran, and colleagues investigated the effect of caffeine restriction on the improvement and severity of PMNE in a involving 534 aged 6 to 15 years. Caffeine consumption was <30 mg/day in the intervention group and 80 to 110 mg/day in the control group.

Before caffeine restriction, the mean number of bed-wettings was 3.5 and 3.4 times/week in the intervention and control groups, respectively. The researchers found that at one month after the intervention, the mean number of bed-wettings was 2.3 and 3.2 times/week in the intervention and control groups, respectively. In the intervention group, caffeine restriction significantly reduced the severity of enuresis. Improvement (dry at night) occurred in 20.2 and 6.7% of children in the caffeine restriction and control groups, respectively, with a relative risk of 0.615. Caffeine restriction significantly reduced enuresis, with a number-needed-to-treat of 7.417.

“Caffeine restriction can help reduce PMNE or its severity,” the authors write. “Constructive limitation of is suggested as one of the first-line treatments in the management of PMNE.”

More information:
Sadra Rezakhaniha et al, Limited caffeine consumption as first-line treatment in managing primary monosymptomatic enuresis in children: how effective is it? A randomised clinical trial, BMJ Paediatrics Open (2023). DOI: 10.1136/bmjpo-2023-001899

2024 HealthDay. All rights reserved.

Citation:
Caffeine restriction can improve, reduce severity of bed-wetting (2024, February 2)
retrieved 3 February 2024
from https://medicalxpress.com/news/2024-02-caffeine-restriction-severity-bed.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




medicalxpress.com

Check Also

New imaging technique accurately detects aggressive kidney cancer

Representative imaging with [89Zr]Zr-girentuximab. Credit: The Lancet Oncology (2024). DOI: 10.1016/S1470-2045(24)00402-9 A new study led …

Leave a Reply

Available for Amazon Prime
??.